Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2017
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist <sup>68</sup>Ga-RM2: Preliminary results in patients with negative or inconclusive [<sup>18</sup>F]Fluoroethylcholine-PET/CTGesche Wieser, Ilinca Popp, H Christian Rischke, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|February 18, 2021
The adaptation and feasibility of dialectical behaviour therapy for adults with intellectual developmental disabilities and transdiagnoses: A pilot community-based randomized controlled trialJessica Jones, Ashleigh Blinkhorn, Meg McQueen, et al.
The Journal of Urology|February 13, 2014
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomographyCordula A Jilg, Wolfgang Schultze-Seemann, Vanessa Drendel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2014
Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection onlyHans Christian Rischke, Wolfgang Schultze-Seemann, Gesche Wieser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2020
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancerNicole Wiedenmann, Anca-Ligia Grosu, Martin Büchert, et al.
Radiation Oncology (London, England)|May 3, 2018
Focal dose escalation for prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology referenceConstantinos Zamboglou, Benedikt Thomann, Khodor Koubar, et al.
Theranostics|January 3, 2017
Comparison of <sup>68</sup>Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathologyConstantinos Zamboglou, Vanessa Drendel, Cordula A Jilg, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Head and neck paragangliomas: clinical and molecular genetic classificationChristian Offergeld, Christoph Brase, Svetlana Yaremchuk, et al.
Radiation Oncology (London, England)|August 31, 2018
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PETNicole Wiedenmann, Hatice Bunea, Hans C Rischke, et al.
Radiation Oncology (London, England)|September 23, 2018
Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PETNicole Wiedenmann, Hatice Bunea, Hans C Rischke, et al.
Pageof 11